Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-09-013030

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BRADSHER NEAL C · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2009-07-02 Grant or award : show line 1 in the form Option to purchase common shares +20,000 $2.30 2014-07-01 20,000 20,000 D
Loading xslF345X03/p1010919_ex.xml…